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Disturbances in sustained attention commonly interfere
with the ability of persons with schizophrenia to benefit
from evidence-based psychosocial treatments. Cognitive re-
mediation interventions have thus far demonstrated mini-
mal effects on attention, as have medications. There is
thus a gap between the existence of effective psychosocial
treatments and patients’ ability to effectively engage in and
benefit from them. We report on the results of a multisite
study of attention shaping (AS), a behavioral intervention
for improving attentiveness and learning of social skills
among highly distractible schizophrenia patients. Patients
with chronic schizophrenia who were refractory to skills
training were assigned to receive either the UCLA Basic
Conversation Skills Module (BCSM) augmented with
AS (n 5 47) or in the standard format (n 5 35). AS, a
reward-based learning procedure, was employed to facili-
tate patients’ meeting clearly defined and individualized
attentiveness and participation goals during each session
of a social skills training group. Primary outcomemeasures
were observational ratings of attentiveness in each session
and pre- and post-BCSM ratings of social skill and symp-
toms. Patients receiving social skills training augmented
with AS demonstrated significantly more attentiveness in
group sessions and higher levels of skill acquisition; more-
over, significant relationships were found between changes
in attentiveness and amount of skills acquired. Changes in
attentiveness were unrelated to level or change in antipsy-
chotic medication dose. AS is an effective example of sup-
ported cognition, in that cognitive abilities are improved
within the environmental context where the patient is ex-
periencing difficulty, leading to gains in both attention
and functional outcome.
Key words: cognitive rehabilitation/outcome/recovery/
cognition/attention/neurocognitive deficit
Attention deficits have long been recognized as charac-
teristic of many people with schizophrenia1–3 and can
be found as early as the first illness episode.4 More re-
cently, researchers have documented that these impair-
ments interfere with the ability to fully engage in, and
benefit from, evidence-based psychosocial treatments
that can significantly reduce disability (eg, skills training,
family psychoeducation, supported employment).5–10
To date, antipsychotic medications have been found to
yield only small improvements in cognition.11–15 More-
over, currently popular rehabilitative approaches to
treating cognitive deficits in schizophrenia do not address
attention,16,17 have not been shown to improve atten-
tion,18–23 have never been tested with more disabled
patients,19,24–26 or have measured attention using tests
with unknown ecological validity.27 For patients with se-
vere attention deficits, therefore, there is a significant gap
between the existence of evidence-based psychosocial
interventions and their ability to effectively engage in
them. However, evidence from several lines of research
suggests that an approach that is motivation based,
that utilizes an individually tailored gradient of task dif-
ficulty, and that is embedded within a meaningful perfor-
mance context is likely to produce real-world gains in
attentiveness via motivational enhancements.
The relationship between motivation and attention
deficits in schizophrenia was noted by Kraepelin,3 who
in 1919 wrote that the lack of motivation observed in
many patients ‘‘is without doubt clearly related to the dis-
order of attention which we very frequently find conspic-
uously developed in our patients. It is quite common for
them to lose both the inclination and ability on their own
initiative to keep their attention fixed for any length of
time.’’(p5–6) More recent experimental work supports
the role of motivational deficits in the poor cognitive per-
formance of schizophrenia patients.28–30
One method to coordinate motivational functions
and attention in schizophrenia involves increasing the
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strength of reinforcers. This can also be viewed as a form
of increasing the affective salience of a task, a strategy
that has been demonstrated to improve cognitive test per-
formance.31 Evidence consistently indicates that using
monetary rewards and other powerful secondary rein-
forcers can improve the performance of schizophrenia
patients on cognitive tests, including tasks where poor
performance has been considered a vulnerability marker
of the illness.32–35 In addition, all past published reports
involving the pairing of primary or secondary reinforcers
with the behavioral response of attentive behavior have
demonstrated significant improvements, even among the
most disabled patients in state hospital settings.36–42
Findings that schizophrenia patients are responsive to
operant conditioning procedures,43 that they are respon-
sive to the motivational significance of ongoing events,44
that patients attribute motivational importance to rele-
vant events,45 and that positive social interactions im-
prove cognitive functioning in schizophrenia31 provide
a further rationale for using external reinforcers as
a method to increase motivation for engaging in attentive
behaviors in the treatment environment.
In this report, we describe the results of a multisite
study of attention shaping (AS) for highly distractible,
chronic schizophrenia patients. All patients in the study
were already engaged in intensive psychiatric rehabilita-
tion, either in a state hospital inpatient or partial hospital
setting. All patients also hadmarked impairments in both
social skills and attentiveness and had received multiple
forms of skills training without any obvious clinical ben-
efit or significant progress toward being discharged from
their respective programs. The specific aim of the study
was to determine whether integrating AS into a skills
training group would lead to increases in attention and
skill acquisition compared with standard presentation
of the group. Secondary aims were to determine if AS
had effects on psychiatric symptoms and whether any ob-
served effects of AS could be accounted for bymedication
dose or dose changes. Based on prior studies and case
reports of earlier versions of this intervention, we hypoth-
esized that AS would significantly enhance both atten-
tiveness and skill acquisition but that it would not
affect symptoms. We also hypothesized that effects of
AS would be independent of medication effects.
Method
Study Design
Patients were assigned either to receive the UCLA Basic
Conversation Skills Module (BCSM) augmented by AS
or the BCSM in its standard format. Prior to, and then
after, group treatment, all patients had their conversation
skills and symptoms assessed. Attentiveness was mea-
sured in every group session using an observational, in-
terval sampling, coding method described in the outcome
measures section below.
Subjects
All study participants met Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition, Text Revi-
sion, criteria for schizophrenia, as determined either by
structured clinical interviews or review of the extensive,
long-term, medical records that were available. In addi-
tion, all subjects were between the ages of 18–55 years,
without a history of head trauma with loss of conscious-
ness, neurologic illness, or active substance abuse during
the 3 months prior to study entry. The final sample con-
sisted of 82 people (50 men, 32 women). Data were col-
lected from 3 study sites: (1) the Second Chance Program
at theWestchester Division of the NewYork Presbyterian
Hospital-Weill Medical College of Cornell University,46
a social learning-based, long-term inpatient rehabilita-
tion program at a private hospital for state hospital
patients considered to be treatment refractory and with
a continuous state hospital stay of at least 3 years prior
to transfer (n = 38; 74%male; 50% African American, 1%
Asian American, 13% Hispanic); (2) the Community
Transition Program at the Lincoln Regional Center,
an academically affiliated state hospital program that
uses a psychiatric rehabilitation model47 (n = 23; 52%
male; 10% African American; 4% Hispanic); and (3)
a partial hospital program at the University of Illinois
at Chicago (UIC) Hospital (n = 21; 48% male; 81% Af-
rican American; 5% Asian American).
At all sites, potential subjects were identified by pro-
gram nurses as being among the most disabled third of
people in the program in terms of attentional disability.
As a check on these lists, at the Cornell site, the program’s
recreational therapist completed, for each patient, an ob-
servationalmeasure of attentiveness48 thatwas amodified
form of the Rating Scale of Attentional Behavior.49 Re-
liability in terms of concordance between the 2 methods
for identifying subjects as being in the bottom third of
functioning level was high, with a kappa coefficient based
on all pairs of ratings of 0.78.
Subjects were randomized into either of 2 treatment
conditions: AS plus BCSM or BCSM alone. However,
during the final round of groups, all sites only ran groups
using AS in order to maximize data on correlates of AS
treatment response and potential medication effects (see
below, Results). Therefore, the final enrollment numbers
by condition (AS = 47, comparison = 35) reflected a de-
liberate recruiting strategy and not subject dropout. All
subjects who completed the initial baseline assessment
attended enough group sessions so that statistics on
changes in attentiveness could be calculated. However,
not all subjects were available to complete the posttreat-
ment assessment measures because of subject dropout or
planned discharge from the larger treatment program.
The number of subjects available at posttreatment did
not differ between the treatment conditions, with 79%
Attention Shaping
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and 77% completing the posttests from the AS and com-
parison conditions, respectively.
Interventions
Basic Conversation Skills Module. All subjects partici-
pated in the BCSM,50 a manualized, structured, skills
training program that is one of the interventions of the
UCLA Social and Independent Living Skills series.51,52
The BCSM contains 5 skill areas: recognizing verbal
and nonverbal cues, starting a friendly conversation,
keeping a conversation going (eg, changing topics, asking
questions, determining context-appropriate levels of self-
disclosure, using active listening skills), ending a conver-
sation, and putting all the skills together. Each skill area
is taught using 7 standard learning activities that are
based on behavioral principles and that include abundant
positive reinforcement, in the form of verbal praise for
effort and appropriate responses. Six patients were en-
rolled in each group in each treatment condition during
each round of groups. The BCSMwas run twice per week
at all sites for 1-hour sessions. The median number of ses-
sions to complete each round of the BCSM, across all
sites for the 2þ years of data collection, was 34.
Shaping. Shaping refers to the application of reward-
based learning techniques to bring about new behavior
or to modify an existing behavior. The primary technique
involved is differential reinforcement of incremental
changes that represent successive approximations toward
a target behavior. For example, rather than waiting for
a desired behavior (eg, a 20-minute attention span) to oc-
cur before offering reinforcement, reinforcement is
provided for successive approximations or steps toward
the final behavior, beginning at a point where the person
is already able to succeed. When the initial step toward
a behavior (eg, 2 minutes of continuous attention) has
been reinforced and occurs fairly regularly, the criterion
for reinforcement is advanced to the next step (eg, 3
minutes of attention). This sequence of reinforcing,
changing the criterion for reinforcement, fading rein-
forcers for previous versions of the behavior, and limiting
reinforcers to behavior meeting the new criterion is
then repeated until the behavior resembles the desired
response. A strength of shaping therefore is that it can
be used to develop and strengthen behavior that does
not normally occur or else occurs at a very low frequency
(eg, attentiveness).
Attention Shaping. Beginning in the third session, ini-
tial, individualized, attentiveness goals were established
for each subject in the AS condition, based on the median
length of observed attentiveness intervals for that patient
during the first 2 group sessions. These individualized
goals and operational criteria for attentiveness and inat-
tentiveness (which were displayed on a poster used during
AS sessions only) were reviewed at the beginning of this
and each subsequent AS session. Goals were expressed in
2 parts: (1) duration of attentiveness (ie, ‘‘subtarget’’) (eg,
2 consecutive minutes of attentiveness) and (2) howmany
times the subtarget had to be met during the session (ie,
‘‘class target’’) (eg, 4 times). Each time a patient met an
attentiveness duration goal, he/she received 2 forms of re-
inforcement: (1) verbal praise that included a mention of
the subtarget that was met and (2) a shaping ticket that
indicated that one subtarget was met. At the end of each
AS session, shaping tickets were collected and each
patient’s performance relative to his/her class target
was reviewed in front of the group. Patients who received
enough shaping tickets to meet their individualized class
target received a tangible reinforcer in the form of $2 and
a reminder that this was being given to them because they
successfully met their goal in the session that day. Sub-
jects who met their class target for 2 consecutive sessions
were moved to the next goal in a prespecified hierarchy.
Subjects who failed to meet their targets for 2 consecutive
sessions had their attentiveness criteria reduced to the
next lowest goal in the series.
Group sessions for both treatment conditions had 2
trainers. BCSM groups without AS had a group leader
and a cotherapist. AS groups had a group leader and
a change agent. The role of the change agent was to ob-
serve subjects during the session and to briefly interact
with them around their attentive and/or inattentive
behaviors. These interactions were of several prespecified
types. For example, each time a patient met a subtarget,
the change agent would verbally reinforce the person with
specific feedback (including praise and identification of
the subtarget that was met) and hand him/her a shaping
ticket. Verbal positive reinforcement could also occur
part-way through subtarget periods. For example, if
a patient’s subtarget was 10 minutes, and he/she had
been paying attention for 5 consecutive minutes thus
far, the change agent might verbally praise him/her for
5 minutes of continuous attention and note that another
5 minutes of continuous attention would lead to earning
the next shaping ticket. Inattentive behaviors were
addressed with specific prompts and extinction to ensure
that attentive behavior was reinforced by staff more than
inattentive behavior. Instances of inattentive behavior
were addressed using a negative-positive prompt se-
quence. This included a specification of the inattentive
behavior that occurred and a statement that this was
an example of not paying attention that is interfering
with the ability to earn the next shaping ticket. This neg-
ative prompt was followed by a positive prompt, remind-
ing the patient that engaging in specific personally
relevant behaviors from the ‘‘attentive behaviors’’ por-
tion of the chart (see table 1) would help the person
earn the next shaping ticket. If the patient resumed atten-
tive behavior, this was reinforced with specific verbal
praise, commenting on the attentive behavior. Continued
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inattention was not responded to (ie, not reinforced) in
order to extinguish the behavior. For subjects in the
comparison condition, verbal reinforcement also oc-
curred after giving correct answers or other efforts at
participation but neither specific feedback about dura-
tion of attentive behaviors nor shaping tickets were
given. Inattentive behaviors were commented on by staff
in the comparison condition as well, but the specific
prompting sequences used in the AS groups for redirect-
ing patients toward attentive behavior, including men-
tioning of reinforcers for attentive behavior, were not
used in this condition.
The trainers for this study included both research staff
and existing agency staff, including nurses, social work-
ers, occupational therapists, recreational therapists, and
mental health workers. In-person training at sites in New
York and Illinois in both the BCSM and in AS was pro-
vided by the first author. Training at the Nebraska site
was provided by the second author, with 2 observational
visits during the course of the study by the first author. In
addition, the third author visited each of the sites during
the study period to train, observe, and provide feedback
to staff on their delivery of the AS intervention. All staff
conducting the BCSM exceeded 80% criteria on the
UCLA Therapist Fidelity Checklist for Modules51 as
rated by the site PI. In addition, a Therapist Fidelity
Checklist for AS was developed at the beginning of
this project. All staff who served as change agents
were given copies of this checklist, and it was reviewed
during regular supervision meetings for the study. Man-
uals describing all AS and rating procedures are available
from the first author.
Outcome Measures
The primary outcomemeasures for this study were the (1)
parameters characterizing attentive behavior displayed
by subjects during group sessions for both treatment con-
ditions and (2) pre-post change in scores on the Compre-
hensive Module Test for the BCSM.51 The latter is
a structured interview for assessing knowledge of infor-
mation taught in the group, social problem–solving skills,
and ability to demonstrate social skills in brief, structured
role-plays. Symptom levels were assessed before and after
the BCSM using the Positive and Negative Syndrome
Scale (PANSS),53 which was scored using a 5-factor
model.54 Interrater reliability was calculated across all
symptom ratings for all pairs of raters at each site.
The average intraclass correlation was .89. At the Lincoln
site only, symptom data were also available from the
Nurses Observational Scale of Inpatient Assessment
(NOSIE).55
Attentiveness Ratings. For subjects in both conditions,
interval-sampled, observational ratings of attention were
begun in the initial BCSM session. A noninteractive rater
observed each subject for 10 consecutive seconds (using
a stopwatch) each minute and coded each segment as ei-
ther attentive or inattentive, based on specific, operation-
alized criteria for attentiveness and inattentiveness (see
table 1). Each subject was observed during the same
10-second interval each minute. For a subject to be
coded as attentive, he/she would have to meet criteria
for attentiveness, with no instances of inattentive behav-
ior, for the entire 10-second interval.
Reliability of Attentiveness Ratings. Reliability of atten-
tiveness ratings was ensured through several procedures.
First, a training videotape and a rating manual were cre-
ated. The videotape contained part- or full-session close-
up views of 3 patients participating in skills training
group sessions. The manual contained detailed instruc-
tions for attentiveness rating procedures and explana-
tions of coding decisions for each of the four hundred
sixty-six 10-second intervals on the training tape. Scores
for each rater were compared with the gold standard rat-
ings in the manual (developed by SMS, AM, and HS) to
determine kappa coefficients. All attentiveness raters for
this study and an outside consultant (AM) observed and
rated this tape each year of the study to minimize rater
drift. The average kappa coefficient across all pairs of
raters (42 pairs of ratings in total) for the duration of
the study was .75, indicating adequate interrater reliabil-
ity. Second, each rater at each site created a tape each
year that was sent to the first author and consultant
and these ratings were compared. The average kappa
Table 1. Attention Span was Operationally Defined as Engaging
in Behaviors from theFirst 2 of the FollowingCategories andNot
Engaging in Behaviors From the Third Category
A. Attention focused on class
1. Head up
2. Eyes open
3. Looking at trainer/video/role-play
B. Active participation in class
1. Verbally responds to questions, requests, instructions within
5 seconds
2. Verbal responses are relevant (i.e., on topic)
3. Verbal responses consist of more than one or two words
when indicated
4. Participates in role-plays (may not get everything just right,
but tries)
5. Makes spontaneous comments or comments/asks questions
when trainer addresses whole group.
C. Participation interfering behaviors
1. Making irrelevant verbalizations/gestures, including talking
out loud or to self or gesturing not in response to anyone
in the room
2. Arguing, yelling, screaming, etc
3. Staring off into space
4. Getting out of chair or leaving group
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coefficient for these 6 pairs of ratings was .78. It is impor-
tant to note that attention raters were not blind to subject
condition because it is not possible to observe the shaping
and control groups without being aware of which condi-
tion is being observed.
Medication. Total daily dosage of antipsychotic medi-
cation was recorded for each day a group was conducted,
for 70% of patients (randomly determined), to examine
the potential effects of medication on attentive behavior.
Chlorpromazine (CPZ) equivalent doses for second-
generation antipsychotic medications were derived using
published equivalence ratios available at the start of the
study.56
Data Analysis
Change in attentiveness over time was analyzed in 2 ways.
First, the average total minutes of attentiveness per group
during each subject’s first 2 (attended) group sessions was
compared with this average for their final 2 sessions. Sec-
ond, each patient’s time series of attentiveness scores
(across all sessions attended) was characterized by 3
parameters: (1) the mean of the dataset, (2) the slope
of the regression line through all data points, with the
first-order autoregressive component removed, and (3)
the root mean square error (RMSE), representing the av-
erage daily deviation of each patient from his/her own
corrected regression line. These parameters are ideal to
characterize variability in dynamic systems over time57
and have been useful in analyzing treatment response
to psychiatric rehabilitation interventions.58 In addition
to examining the variable of total minutes of attentive-
ness in each group, we examined the average duration
of discrete periods when attentiveness was demonstrated.
Effects of medication on attentiveness were examined by
calculating the correlation between daily attentiveness
ratings and daily CPZ equivalent dose for each subject.
The 2 groups were then compared on the mean values of
these correlations. For all analyses related to the study’s
specific aims, effect sizes are reported using Cohen d.
Results
Means and SDs for pretest and posttest values are found
in table 2. The 2 treatment conditions did not differ in age
(t76.6) =0.86,P = .39) or education level (t54.9 = 0.81, P =
.42). At baseline, the AS and comparison groups did not
differ on daily antipsychotic medication dose (t56 =
1.18, P = .25). The AS and comparison conditions
also did not differ on number of sessions missed by group
members (t79 = 0.90, P = .37). AS condition subjects
missed a median of 2 groups (range = 0–25), and compar-
ison condition subjects missed a median of 4 sessions
(range = 0–28).
Effects of AS on Attentiveness
Total Attentiveness. The 2 conditions did not differ on
baseline attentiveness, as reflected in observational
Table 2. Means (SDs) for Baseline, and Treatment Response Data, by Condition
AS
a
Comparison
Age 38.17 (11.15) 40.20 (10.19)
Years of education 11.55 (1.88) 11.13 (2.41)
Daily antipsychotic medication dose, in chlorpromazine equivalents 964 (586) 1131 (537)
Mean number of study group sessions missed 6.15 (7.39) 7.69 (7.86)
Total minutes of attentiveness per session in first 2 sessions 15.73 (10.50) 14.99 (10.26)
Total minutes of attentiveness per session in final 2 sessions
b
24.84 (11.80) 16.94 (9.40)
Improvement in total minutes of attentiveness from first 2 to last 2 sessions, in minutes
b
9.11 (10.40) 1.96 (7.20)
Slope of change in total minutes attentiveness per session across all sessions, in degrees
b
19.60 (16.70) 1.70 (1.23)
Mean duration of attentiveness episodes in first 2 sessions, in minutes 2.87 (3.94) 2.78 (2.70)
Mean duration of attentiveness episodes in final 2 sessions, in minutes
b
6.39 (7.55) 3.41 (2.41)
Improvement in mean duration of attentiveness episodes from first 2 to last 2 sessions, in minutes
b
3.52 (7.52) 0.63 (3.17)
Slope of change in mean duration of attentiveness episodes, across all sessions, in degrees
b
13.10 (24.7) 1.80 (3.80)
Pretreatment score on Comprehensive Module Test for BCSM
c
12.24 (6.68) 13.94 (8.15)
Posttreatment score on Comprehensive Module Test for BCSM
c
24.94 (9.23) 23.14 (10.51)
aAS, attention shaping.
bStatistically significant (see Results section).
cBCSM, UCLA Basic Conversation Skills Module. The treatment group 3 time (pre-post) interaction was statistically significant.
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ratings of attentiveness during the first 2 BCSM sessions
(a total of 90 observations per patient): t77 = 0.32, P = .75.
However, during the final 2 sessions, the AS condition
demonstrated a significantly higher degree of attentive-
ness: t77 = 3.31, P = .001, d = 0.74 (see figure 1). A
mixed-model analysis of variance (ANOVA) indicated
a significant main effect of time (ie, pre- to posttreatment)
on attentiveness ratings (F1,77 = 28.70,P< .001) and a sig-
nificant group 3 time interaction effect (F1,77 = 11.99, P =
.001). There was a 4.65 times greater degree of change for
the AS condition compared with the comparison condi-
tion, t75.7 = 3.61, P = .001, d = 0.89.
The most sensitive index of change is the slope of
change over time, across all sessions, corrected for the
first-order autoregressive component. The AS condition
demonstrated a significantly steeper slope of improve-
ment over time than the comparison condition, an
11.53 orders of magnitude difference, t77 = 5.28, P <
.001, d = 1.51. The 2 groups did not differ in the extent
to which individual patients varied around their cor-
rected slopes, as indexed by the RMSE of the daily atten-
tiveness ratings, t77 = 0.60, P = .55.
Duration of Attentiveness Episodes At baseline, the 2
groups did not differ on their average duration of atten-
tiveness episodes: t75.5 = 0.12, P = .91. However, during
the final 2 group sessions, the AS group demonstrated
significantly longer durations of attentiveness: t53.6 =
2.46, P < .05, d = 0.53 (see figure 2). A mixed-model
ANOVA indicated a significant main effect of time on
attentiveness ratings (F1,77 = 9.31, P < .005) and a signif-
icant group 3 time interaction effect (F1,77 = 4.51, P =
.05). There was a 5.59 times greater degree of change
for the AS condition compared with the comparison con-
dition, t60.5 = 2.30, P < .05, d = 0.50.
As with the total attentiveness index, the AS condition
demonstrated a significantly larger corrected slope of
change over time, t77 = 2.66, P< .01, d = 0.64. The groups
also differed in their day-to-day variability in duration of
attentiveness episodes, as reflected in RMSE scores, with
AS subjects demonstrating more variability around their
individual corrected regression lines, t53.5 = 2.71, P< .005.
Effects of AS on Skill Acquisition
The AS and comparison conditions were equivalent in
their scores at baseline on the Comprehensive Module
Test for the BCSM (t79 =1.03,P = .30). After treatment,
the groups also did not differ significantly on their test
scores, although the relative ordering of means was re-
versed (t61 = 0.72, P > .47]. A 2-way mixed-model
ANOVA (group 3 time) indicated that there was a signif-
icant main effect of time, indicating that scores improved
from pre- to posttesting (F1,61 = 139.60, P < .001) and
a significant group 3 time interaction effect, with the
AS condition demonstrating greater improvement than
the comparison condition on the ComprehensiveModule
Test from pre- to posttesting (F1,61 = 8.70, P = .005, d =
.72). Increases relative to baseline were 104% and 66.7%
for the AS and comparison conditions respectively, and
the group differences in pre-post difference scores was
significant, t61 = 2.95, P = .005.
Relationships between Changes in Attentiveness and
Learning of Behavioral Skills
Change in observational ratings of attentiveness from the
first 2 to final 2 sessions was significantly correlated with
change in social skill and recall of group content, as mea-
sured by the Comprehensive Module Test, r62 = .36, P <
.005. This indicates that improvement in attentiveness
over time was associated with improved skill acquisition.
Effects on Symptoms
The conditions did not differ at baseline on positive, neg-
ative, excitement/hostility, or anxiety/depression scores
on the PANSS. However, the AS condition had a higher
level of disorganized symptoms at baseline, t78 = 2.13,P<
.05. The same pattern was observed at the end of the
study groups; for disorganized symptoms, t61 = 2.23,
P < .05. Analysis of pregroup and postgroup NOSIE
data from the Lincoln site (n = 23) indicated that the
AS (n = 12) and comparison conditions (n = 11) did not
differ at either baseline [AS = 137.29 (38.38),
comparison = 150.14 (15.45), t14.7 =1.07,P = .30] or after
treatment[154.25(38.33)vs159(19.54),t21=0.46, P = .64].
Fig. 2. Pre- to Post-Treatment Changes in Average Duration of
Continuous Attentiveness Episodes (in Minutes), by Treatment
Condition.
Fig. 1. Pre- to Posttreatment Changes in Total Number ofMinutes
of Attentiveness per Session, by Treatment Condition.
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A 2 (group) 3 2 (time) mixed-model ANOVA indicated
a significant main effect of time (F1,21 = 7.98, P = .01),
but the group 3 time interaction effect was not signifi-
cant (F1,21 = 0.78, P = .39). These data indicate not
only that AS did not have a significant differential
effect on symptoms, consistent with past evidence of
independence of cognitive and symptom treatment
effects16 but also that despite a higher level of disorga-
nized symptoms at baseline and after treatment for the
AS condition there was still significantly greater change
in attentiveness and skill acquisition for these patients.
Medication and Treatment Response
Of the 58 patients on whom medication data was avail-
able, 38 (46% of the total enrolled sample) demonstrated
change in both attentiveness and medication dose across
sessions, allowing for a statistical analysis of relation-
ships between change in each variable over time. For
this subsample, change in daily CPZ equivalent dose
was not significantly correlated with change in attentive-
ness: AS (n = 20), mean r = 0.04, comparison (n = 18),
mean r = 0.06, t33.5 = 0.95, P = .35. For the 20 patients
for whom there was no change in antipsychotic medica-
tion dose during study participation, changes in atten-
tiveness were, by definition, independent of CPZ
equivalent (all patients demonstrated variability in atten-
tiveness over time).
Site Effects
The 3 sites did not differ on education level (F2,71 = 2.05,
P > .13) or age (F2,80 = 0.30, P > .74). There was a sig-
nificant difference at baseline on PANSS positive symp-
tom ratings (F2,78 = 12.93, P< .001), with post hoc Tukey
Honestly Significant Difference (HSD) tests indicating
that patients at the Cornell site had significantly greater
symptomatology than patients at both other sites
whereas patients at the Lincoln and UIC sites did not dif-
fer from each other. A similar pattern of main effects and
post hoc between-group differences was observed with
PANSS negative symptom ratings (F2,78 = 4.75, P <
.05), PANSS cognitive symptom ratings (F2,78 = 30.73,
P < .001), and PANSS excitement symptom ratings
(F2,78 = 7.76, P = .001). For PANSS depression ratings,
there was a main effect of group (F2,78 = 8.44, P < .001).
Post hoc Tukey HSD tests indicated that patients at the
Cornell site had significantly greater symptomatology
than patients at the Lincoln but not the UIC site. Patients
at UIC also had significantly greater depressive symp-
tomatology than patients at the Lincoln site. On baseline
levels of social skill, as rated by the ComprehensiveMod-
ule Test for the BCSM, there was a significant site differ-
ence (F2,79 = 9.88, t < .001). Post hoc Tukey HSD tests
indicated that patients at the Cornell site demonstrated
lower scores on this measure than patients at the other
2 sites, who did not differ from each other. On baseline
levels of attentiveness, as indicated by the total number of
minutes of attentiveness during the first 2 group sessions
(before AS was introduced), there was a significant main
effect of site (F2,77 = 20.09, P < .001). Post hoc tests in-
dicated that the Cornell group was rated as the least at-
tentive, followed by patients at Lincoln and then at UIC.
All between-site comparisons were significant. On the
variable of mean duration of attentiveness episodes for
the 2 baseline group sessions, there was a significant
main effect of site (F2,77 = 5.88, P < .005). Post hoc tests
indicated that the Cornell group demonstrated signifi-
cantly briefer durations of attentiveness than patients
at Lincoln or UIC, who did not differ from each other.
Taken together, the results of site comparisons on base-
line variables indicate that patients at Cornell were
a much more symptomatic and disabled group than
patients at the other 2 sites, while patients at the UIC par-
tial hospital program were the least symptomatic and
least impaired, although not significantly so compared
with patients at Lincoln in some respects.
Potential effects of site on treatment outcomes were ex-
plored by comparing the 3 study sites on the 3 critical var-
iables from this study: slope of change in total minutes of
attentiveness per group, slope of change of mean dura-
tion of attentiveness episodes per group, and skill acqui-
sition (defined as posttreatment minus pretreatment
scores on the Comprehensive Module Test for the
BCSM). See table 3 for means and SDs of these variables
by site and group (AS vs comparison). All analyses in-
volving main effects of site and group, site by group in-
teraction effects and within-site between-group effects
are reported below, although note that within-site effects
for Lincoln and UIC are underpowered. For the ‘‘slope
of total attentiveness’’ variable, there were main effects
of site (F2,73 = 3.09, P < .05) and group (F1,73 = 44.00,
Table 3. Means (SDs) for Critical Study Variables, by Site
AS Comparison
Slope—total minutes of attentivenessa
Cornella 11.8 (15.4) 1.5 (9.4)
Lincolna 27.4 (15.4) 4.3 (13.4)
UICa 31.1 (16.6) 0.8 (15.2)
Slope—mean duration of attentiveness episodesa
Cornell 3.2 (6.1) 0.9 (2.3)
Lincolna 14.7 (14.8) 3.2 (5.4)
UICa 40.1 (46.0) 1.6 (3.5)
Skill acquisitionab
Cornella 14.40 (7.72) 5.67 (5.99)
Lincoln 11.27 (6.80) 5.57 (7.16)
UIC 12.20 (4.92) 13.25 (5.15)
aStatistically significant (see Results section).
bSkill acquisition is operationally defined as posttest scores on
the Comprehensive Module Test for the UCLA Basic
Conversation Skills Module minus pretest scores on the same
measure.
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P< .001), and the site 3 group interaction was significant
(F2,73 = 3.96, P < .05). Inspection of table 3 reveals that
the AS patients at the Cornell site (who had been consid-
ered to be treatment refractory at local state hospitals)
had the smallest improvement, although it was still
over 6 times greater than the improvement in the compar-
ison group at this site. AS patients at the state hospital in
Lincoln demonstrated the next highest level of improve-
ment, followed by the partial hospital patients at UIC.
The mean slope values for the comparison groups at
all 3 sites were close to zero. At all 3 sites, the effect of
treatment condition was significant (Cornell: t36 = 2.26,
P < .05; Lincoln: t21 = 4.50, P < .001; UIC: t16 = 4.24,
P = .001).
For the ‘‘slope of the mean duration of attentiveness’’
variable, there were main effects of site (F2,73 = 8.27, P =
.001) and group (F1,73 = 21.08, P < .001), and the site 3
group interaction was significant (F2,73 = 7.69, P = .001).
Again, the Cornell patients demonstrated the smallest
degree of change (although still 3 times greater than
the comparison group), followed by Lincoln and then
UIC. At the Cornell site, the difference between groups
approached significance (t32.2 = 1.67, P< .11), whereas at
the Lincoln (t14.1 = 2.51,P< .05) andUIC (t7.1 = 2.37,P =
.05) sites, the differences between groups were significant.
For skill acquisition, only the main effect of group was
significant (F1,57 = 5.72, P > .23), in contrast to the main
effect of site (F2,57 = 1.47, P > .23) and the site 3 group
interaction effect (F2,57 = 2.31, P> .10). Both the Cornell
and Lincoln sites demonstrated large differences between
the AS and comparison conditions. The effect of group
was significant at the Cornell site (t30 = 3.35, P = .002) but
was not at Lincoln (t16 = 1.70, P < .11). At the UIC site,
the means were not significantly different, and in contrast
to the other sites, the comparison group demonstrated a
similar degree of change to the AS group (t11 = 0.36,
P > .72).
Discussion
This multisite effectiveness study of AS in chronic schizo-
phrenia demonstrated that it significantly improved at-
tentiveness in group sessions and increased overall skill
acquisition. Moreover, the effect sizes associated with
these changes were medium to very large (0.50–1.51)
and were unrelated to medication changes or overall
dose during study participation. These data indicate
that, just as impaired attention is a rate-limiting factor
for learning in skills training interventions,5 improve-
ments in attentiveness produced via AS mediate en-
hanced learning of skills in skills training.
The patients in this study came from 3 different sec-
tions of the country, were both inpatients and partial hos-
pital patients, were primarily racial and ethnic minorities,
were trained in private and public facilities, and received
training primarily from ‘‘front line’’ staff working at the
facilities. In addition, the patients were on very high doses
of antipsychotic medication, attesting to their complex
and refractory clinical presentations. Thus, the results
of this effectiveness study suggest that AS is a viable pro-
cedure that can be broadly implemented by clinicians
treating schizophrenia patients in a variety of settings.
That AS was effective with patients who were severely
disabled leads one to believe that the procedure would
also be effective with similar types of patients elsewhere
and also with distractible patients who are acutely ill and
even patients with higher initial levels of attentiveness.
Analysis of site effects indicated large effects of AS on
attentiveness at all 3 sites: a specialized treatment unit at
a private hospital for patients who were transferred from
state hospitals due to their being considered treatment re-
fractory, a psychiatric rehabilitation inpatient unit at
a state hospital, and a partial hospital program. In gen-
eral, the magnitude of the between-condition differences
at each site increased as a function of the level of func-
tioning of the patient. In contrast, the effects of AS on
skill acquisition were noted at the 2 inpatient sites
only, not in the partial hospital program. This may reflect
a ceiling effect on the ComprehensiveModule Test for the
BCSM for the UIC group, who achieved the highest pre-
treatment scores, or the greater effect of the BCSM than
AS on skill acquisition for noninpatients, despite the
large effects of AS on attentiveness at this site. The small
number of subjects at the UIC site precludes a definitive
interpretation of this result. We are currently conducting
a large effectiveness trial solely in partial hospital settings
to directly address the issue of the effects of AS on skill
acquisition in community settings.
There were several limitations to this study. One is that
attention raters were not blind to subject condition. This
raises the possibility of rater bias. As noted above, in
Methods, it was not possible to observe the shaping
and control groups without being aware of which condi-
tion was being observed. However, unbiased ratings
could be obtained through assessment of generalizability.
In our current effectiveness study of AS, generalizability
data are being obtained via blind rater observations of
study patients concurrently in nonstudy groups and via
clinical staff ratings of study patients in nonstudy groups.
A second limitation of the study was that we did not col-
lect data on the durability of the AS-related gains. In our
current effectiveness study, we are collecting observa-
tional data at 6-month follow-up in nonstudy groups.
Convergence of blind generalizability and durability rat-
ings with the nonblind in-study group ratings will provide
a stronger set of findings regarding the effects of AS. A
third limitation of this study is that it is not known
whether the improved attentiveness levels of patients
in the AS condition reached the level of patients
who were not considered to need this intervention. Ob-
taining data on the overlap between patients considered
to have minimal attentional impairment (and therefore
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not needing AS), and patients who received AS would
help clarify the functional significance of the effects of
the intervention. A fourth limitation of this study is
that while most of the treatment was delivered by perma-
nent staff at the agency (ie, no new treatment staff were
hired for the study), at the UIC and Lincoln sites in par-
ticular, graduate students in clinical psychology and pre-
doctoral psychology interns (who regularly rotate
through those programs on a yearly basis) were involved
in delivering the interventions. Therefore, it is still not
known what the effects of AS would be when delivered
solely by regular agency staff, not including trainees.
This question will be also answered in our current effec-
tiveness study.
An important feature ofAS is that it is embeddedwithin
a meaningful activity in the patient’s environment. Evi-
dence from the fields of behavioral treatment, social skills
training, academic intervention, and cognitive rehabilita-
tion of TBI patients on training and transfer of behavioral
and cognitive skills suggests that interventions are effective
to the extent that they are embedded within activities and
settings that aremeaningful to the person receiving them.59
This has led to an increased emphasis on supported cogni-
tion interventions that integrate neuropsychological and
behavioral approaches.59–61 The successful integration
of AS with skills training suggests that it might also aug-
ment gains in other interventions requiring sustained at-
tention, such as supported employment and supported
education. Recently, strategies that incorporate shaping
have been used informally to address attentional barriers
to success in supported employment among outpatients
with schizophrenia.62 In addition, an attention-shaping
program was developed collaboratively between an
outpatient with schizophrenia and treatment providers
to successfully increase time spent reading.63 These dem-
onstrations suggest that AS can be incorporated into a va-
riety of settings to improve performance. Consistent with
a recovery orientation, the long-term goal of supported
cognition interventions such as AS is to move patients
from a low base rate of attentive and participatory be-
haviors, to a state of self-determined engagement in re-
warding and necessary activities that is maintained by
self-administered, personally chosen rewards and intrinsic
motivation.64,65 To help achieve this goal, the effects of
AS itself might be augmented by combining it with cogni-
tive behavioral techniques such as activity scheduling
and recording and tracking of pleasure ratings66 and cog-
nitive remediation techniques such as monitoring selective
and sustained attention successes and lapses in natural
environments.48
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